T2 Biosystems, Inc.
NASDAQ:TTOO
0.36 (USD) • At close December 23, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | T2 Biosystems, Inc. |
Symbool | TTOO |
Munteenheid | USD |
Prijs | 0.359 |
Beurswaarde | 7,552,333 |
Dividendpercentage | 0% |
52-weken bereik | 0.31 - 8.38 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. John J. Sperzel III, B.Sc. |
Website | https://www.t2biosystems.com |
An error occurred while fetching data.
Over T2 Biosystems, Inc.
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)